MYUNGMOON Pharm co.,Ltd (KRX:017180)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,722.00
+19.00 (1.12%)
At close: Aug 29, 2025

MYUNGMOON Pharm co.,Ltd Revenue

MYUNGMOON Pharm co.,Ltd had revenue of 48.76B KRW in the quarter ending June 30, 2025, with 5.81% growth. This brings the company's revenue in the last twelve months to 190.76B, up 8.16% year-over-year. In the year 2024, MYUNGMOON Pharm co.,Ltd had annual revenue of 186.44B with 9.95% growth.

Revenue (ttm)
190.76B
Revenue Growth
+8.16%
P/S Ratio
0.31
Revenue / Employee
655.54M
Employees
291
Market Cap
58.60B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024186.44B16.88B9.95%
Dec 31, 2023169.57B17.43B11.46%
Dec 31, 2022152.13B14.38B10.43%
Dec 31, 2021137.76B9.91B7.75%
Dec 31, 2020127.85B-21.49B-14.39%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics5,031.69B
Celltrion3,748.95B
ALTEOGEN158.06B
Yuhan2,165.44B
SK Biopharmaceuticals620.28B
Peptron5.18B
PharmaResearch449.81B
ABL Bio94.93B
Revenue Rankings